China’s Rise in the Global Oncology Market China has rapidly emerged as a global force in oncology, making significant contributions…
Browsing: drug
The innovative approach involves the use of a PET tracer that binds to the antisense oligonucleotide in the brain, allowing…
The FDA is undergoing a significant transition with a 20% reduction in its workforce in April and the departure of…
Dr. Mathai Mammen, a seasoned veteran in the biotech industry, understands the challenges of bringing new drugs to market. With…
GLP-1 drugs have long been hailed for their effectiveness in treating diabetes and obesity. However, a recent study presented at…
Women facing drug use disorder (DUD) or opioid use disorder (OUD) may find increased access to treatment when enrolled in…
Breast cancer is a challenging disease to treat, especially when cancer cells have spread beyond the primary tumor site. Hiroshima…
The U.S. Food and Drug Administration (FDA) is looking to harness the power of artificial intelligence (AI) to expedite the…
Eli Lilly Makes Billion-Dollar Bet on Non-Opioid Pain Drugs Eli Lilly is making a bold move by investing up to…
The push will likely draw lawsuits from the pharmaceutical industry Introduction The Trump administration has been vocal about its efforts…
